ArticleJournal of translational medicine2024

Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells.

Francesca Cirillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.